Roundtable Discussions: Inflammasome Biomarker Strategies

Time: 1:30 pm
day: day 1 post lunch track 2

Details:

  • CNS vs peripheral inflammasome biomarkers
  • Peripheral biomarkers for CNS targeting therapeutics
  • Creating a preclinical and clinical biomarker strategy – where do we go?
  • Effectiveness of downstream biomarkers for inflammasome inhibitors/activators
  • Assessing PET probes for neuroinflammation biomarkers and inflammasome inhibitors